Impact BioMedical, Inc. (IBO)
0.48
-0.01
(-2.04%)
USD |
NYAM |
Sep 03, 16:00
0.485
0.00 (0.00%)
After-Hours: 20:00
Impact BioMedical Research and Development Expense (TTM) : 0.284M for June 30, 2026
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Research and Development Expense (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.284M |
| March 31, 2026 | 0.283M |
| December 31, 2025 | 0.34M |
| September 30, 2025 | |
| June 30, 2025 | |
| March 31, 2025 | |
| December 31, 2024 | |
| September 30, 2024 | 0.728M |
| June 30, 2024 | 0.885M |
| March 31, 2024 | 1.151M |
| December 31, 2023 | 1.147M |
| September 30, 2023 | 1.206M |
| Date | Value |
|---|---|
| June 30, 2023 | 1.297M |
| March 31, 2023 | 1.237M |
| December 31, 2022 | 1.226M |
| September 30, 2022 | 1.139M |
| June 30, 2022 | 0.9987M |
| March 31, 2022 | 1.004M |
| December 31, 2021 | 1.08M |
| September 30, 2021 | 0.8171M |
| June 30, 2021 | 0.75M |
| March 31, 2021 | 0.6856M |
| December 31, 2020 | 0.5137M |
| September 30, 2020 | 0.421M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Enveric Biosciences, Inc. | 2.476M |
| LENZ Therapeutics, Inc. | 3.791M |
| ANI Pharmaceuticals, Inc. | 49.91M |
| Corcept Therapeutics, Inc. | 253.86M |
| Veru, Inc. | 11.76M |